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Huntington's disease (HD) is a hereditary neurodegenerative disease caused by a polyglutamine
expansion within the huntingtin (HTT) gene. One of the cellular functions that is dysregulated in HD is
store-operated calcium entry (SOCE), a process in which the depletion of Ca2þ from the endoplasmic
reticulum (ER) induces Ca2þ inﬂux from the extracellular space. We detected an enhanced activity of SOC
channels in medium spiny neurons (MSNs) from YAC128 mice, a transgenic model of HD, and investi-
gated whether this could be reverted by tetrahydrocarbazoles. The compound 6-bromo-N-(2-
phenylethyl)-2,3,4,9-tetrahydro-1H-carbazol-1-amine hydrochloride was indeed able to restore the
disturbed Ca2þ homeostasis and stabilize SOCE in YAC128 MSN cultures. We also detected a beneﬁcial
effect of this compound on the mitochondrial membrane potential. Since dysregulated Ca2þ homeostasis
is believed to be one of the pathological hallmarks of HD, this compound might be a lead structure for HD
treatment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2. Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.1. Medium spiny neurons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.2. Gene expression analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.3. Immunoblotting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.4. Immunocytochemistry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.5. Application of tetrahydrocarbazoles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.6. Single-cell Ca2þ measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.7. TUNEL staining experiments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.8. Mitochondrial membrane potential (Djm) TMRM assay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.9. ATP quantification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
2.10. Statistical analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3. Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.1. Disturbed Ca2þ homeostasis in YAC128 medium spiny neurons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.2. Effect of tetrahydrocarbazoles on SOCE and Ca2þ release from ER in YAC128 MSNs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
3.3. Tetrahydrocarbazoles 2 and 5 do not affect cell death induced by glutamate in MSN cultures from YAC128 and wild-type mice . . . . . . . . . . . 00
3.4. Tetrahydrocarbazoles increase the mitochondrial membrane potential in YAC128 MSNs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
4. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00dys).
Inc. This is an open access article u
ys, et al., Tetrahydrocarbazole
ease, Biochemical and Biophnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
s decrease elevated SOCE in medium spiny neurons from transgenic
ysical Research Communications (2016), http://dx.doi.org/10.1016/
M. Czeredys et al. / Biochemical and Biophysical Research Communications xxx (2016) 1e122Transparency document . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 00
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 001. Introduction
Huntington's disease (HD) is a neurodegenerative disease
caused by the expansion of a CAG trinucleotide repeat in exon 1 of
the huntingtin gene (HTT), which is translated into polyglutamine
residues (polyQ) in the huntingtin protein (HTT). When the number
of CAG repeats exceeds 36, HTT forms aggregates in the nuclei of
neurons thereby inhibiting the function of various proteins
including key transcriptional factors. This leads to transcriptional
dysfunction and causes neuronal degeneration [1,2]. Huntington's
disease is characterized by multiple changes at the molecular level,
including disturbances in Ca2þ homeostasis and signaling compo-
nents [3,4], and these changes are considered to be involved in
various processes that lead to the neurodegeneration observed in
HD [5,6]. Destabilization of neuronal Ca2þ signaling is one of the
toxic effects of mutant HTT. In medium spiny neurons (MSNs) from
Huntington's disease models mutant HTT perturbs Ca2þ signaling
via at least three mechanisms. Mutant HTT enhances NMDA re-
ceptor function through decreased interaction with the PSD95-
NR1A/NR2B complex [4] and strongly sensitizes the inositol tri-
sphosphate receptor (InsP3R1) to activation by inositol tri-
sphosphate (InsP3) by binding to its carboxy-terminus [7]. This
results in reduced levels of glutamate release from cortico-striatal
projection neurons and leads to supranormal Ca2þ inﬂux via
NMDA receptors and Ca2þ release via the InsP3R1. The increased
efﬂux of Ca2þ from the endoplasmic reticulum (ER) in turn en-
hances store-operated calcium entry (SOCE) from the extracellular
space in MSNs from transgenic YAC128mice [8,9]. The Ca2þ sensors
mediating SOCE are the stromal interaction molecules 1 and 2
(STIM1 and STIM2), which detect changes in Ca2þ concentration in
the ER and aggregate in response to Ca2þ depletion. These aggre-
gates then force the ER membrane towards plasmalemmal sites
where they activate members of the calcium release-activated
calcium channel protein (Orai) family (Orai1, Orai2, and Orai3) or
transient receptor potential channels (TRPC) to induce SOCE
[10e12]. This results in Ca2þ entry by these channels [13,14]. Al-
terations in SOCE lead to mitochondrial dysfunction and cell death
[15,16].
Destabilization of neuronal Ca2þ homeostasis is one of the toxic
functions of the mutant HTT. Therefore, it is vital to search for
compounds that have the ability to restore a healthy balance of
Ca2þ ions. Currently, a few such compounds are being investigated
in clinical trials. Memantine, a modulator of NMDA receptor, has
been shown to protect MSNs in YAC128 HD mice model [17]. This
compound has recently passed the third phase of clinical trials [18].
Riluzol®, another drug that inhibits the activity of NMDAR, how-
ever, failed to pass the clinical trials. Tetrabenazine (TBZ) is an FDA-
approved drug for the treatment of chorea and other hyperkinetic
movement disorders in HD [19]. TBZ is a strong inhibitor of vesic-
ular monoamine transporters (VMAT), which enable a release of
dopamine from presynaptic vesicles. It has been reported that
dopamine and glutamate synergistically create Ca2þ signals in
MSNs [20] e a beneﬁcial effect of TBZ might then result from the
down-regulation of the activity of these signaling pathways.
We have previously studied compounds that restore Ca2þ ho-
meostasis in Alzheimer's disease (AD) [21,22] using human em-
bryonic kidney cells (HEK293) stably overexpressing mutated
presenilin 1 (PS1-M146L), which is responsible for the majority ofPlease cite this article in press as: M. Czeredys, et al., Tetrahydrocarbazol
YAC128 mice, a model of Huntington's disease, Biochemical and Biop
j.bbrc.2016.08.106familial AD cases. These cells showed an increased activity of the
InsP3R in response to carbachol, an agonist of muscarinic acetyl-
choline receptors. Honarnejad and colleagues identiﬁed ﬁve groups
of compounds that substantially decreased carbachol-induced Ca2þ
efﬂux from the ER. One of them, called tetrahydrocarbazoles, was
also able to improve mitochondrial function and attenuate the
production of amyloid-beta (Ab) peptides by decreasing the
cleavage of amyloid precursor protein (APP) by b-secretase [21].
Because increased InsP3R [7] and SOCE activity [8] are also hall-
marks of molecular pathologies of HD, we decided to test whether
the most effective tetrahydrocarbazoles in the AD model were also
able to correct Ca2þ dysregulation in MSNs cultured from YAC128
mice. We report the identiﬁcation of the novel functions of one
tetrahydrocarbazole, which restores the abnormally increased
SOCE and improves mitochondrial function in YAC128 MSNs.
2. Materials and methods
2.1. Medium spiny neurons
MSN cultures were prepared from embryonic day 18 hemizy-
gous YAC128 and wild-type mice striata. Pregnant YAC128 mice
were provided by the Laboratory for Genetically Modiﬁed Animals
of the Mossakowski Medical Research Centre, Polish Academy of
Sciences (Warsaw, Poland). Animal care was in accordance with the
European Communities Council Directive (86/609/EEC). The
experimental procedures were approved by the Local Commission
for the Ethics of Animal Experimentation no.1 inWarsaw (approval
no. 548/2014). Brains were removed from mouse embryos and
collected in cold Hank's solution supplemented with 15 mM HEPES
buffer and penicillin (100 U/mL)/streptomycin (100 lg/mL). Em-
bryo's tails were collected and genotyped by PCR. The striata were
isolated, rinsed three times in cold Hank's solution, and treated
with 2.5% trypsin for 20 min. The tissue was then rinsed in 37 C
Hank's solution and dissociated by pipetting. MSNs were plated in
medium containing DMEM, 10% horse serum, 0.5% glucose, peni-
cillin (100 U/mL)/streptomycin (100 lg/mL) for 2 h. For single-cell
Ca2þ measurements in the 8-well system and immunostaining,
MSNs were plated at a density of 70,000 cells per glass well in
Corning® BioCoat™ Poly-D-Lysine/Laminin Cellware 8-Well Culture
Slides. For single-cell Ca2þ measurements in the perfusion system
and real-time PCR, MSNs were seeded on a cover glass (25 mm in
diameter) coatedwith poly-D-lysine (38 mg/mL; Sigma-Aldrich) and
laminin (2 mg/mL; Roche) at 400,000 cells/plate. After 2 h the
plating mediumwas replaced with the culture medium containing
Neurobasal medium (Invitrogen) supplemented with B27 (Invi-
trogen), 0.5 mM glutamine (Sigma) and a penicillin (100 U/mL)/
streptomycin (100 lg/mL) mixture (Invitrogen). The cultures were
maintained at 37 C in a humidiﬁed 5% CO2/95% air atmosphere.
2.2. Gene expression analysis
Scrapedmaterial fromMSNswas lysed in RNA Lysis Buffer (RLT).
Total RNAwas then isolatedwith an RNeasy Plus Kit (Qiagen). cDNA
was synthesized with random hexamer primers and SuperScript III
RNase H-Reverse Transcriptase (Invitrogen). The samples were
examined by real-time PCR in a 7900HT Real Time PCR System
(Applied Biosystems). Commercial TaqMan primers and probeses decrease elevated SOCE in medium spiny neurons from transgenic
hysical Research Communications (2016), http://dx.doi.org/10.1016/
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Gapdh (control) and HTT. For relative quantiﬁcation, the fold change
in expression was quantiﬁed by normalizing the threshold cycle
(CT) values of the target mRNAs to the CT values of the internal
control Gapdh in the same samples (DCT ¼ CT Target  CT Gapdh). It
was further normalized with the wild-type control
(DDCT ¼ DCT  CT Control). The fold change in expression was then
obtained by calculating 2-DDCT.
2.3. Immunoblotting
MSN cultures were extracted in ice-cold RIPA buffer: 50 mM
Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% NaDOC, 0.1% sodium
dodecyl sulfate (SDS), and 1 mM ethylenediaminetetraacetic acid
(EDTA) that contained mini complete protease inhibitor cocktail
(Roche) and phosphatase inhibitors (Sigma). The lysed cells were
centrifuged at 12,000  g for 10 min. Protein extracts (20 mg) were
separated on 6% SDS-polyacrylamide gel electrophoresis (PAGE),
transferred to a Protran nitrocellulose membrane (Whatman), and
blocked for 2 h at room temperature in TBS-T: 50 mM Tris-HCl, pH
7.5, 150 mM NaCl, and 0.1% Tween 20 plus 5% dry non-fat milk.
Nitrocellulose sheets were then incubated at 4 C overnight in
blocking solution with primary polyclonal antibodies against
huntingtin (Cell Signaling) diluted to 1:500 and GAPDH (Santa
Cruz) diluted to 1:1000 as a control. The horseradish peroxidase-
conjugated secondary antibody anti-rabbit IgG from Sigma was
added at a dilution of 1:10,000 for 1 h at room temperature. The
signal was detected using an enhanced chemiluminescence sub-
strate (Amersham Biosciences).
2.4. Immunocytochemistry
MSNs cultured on Corning® BioCoat™ Poly-D-Lysine/Laminin
Cellware 8-Well Culture Slides were ﬁxed in ice-cold 4% para-
formaldehyde (PFA) and 4% sucrose in phosphate-buffered saline
(PBS) for 15 min at 4 C. After permeabilization in 0.1% Triton X-100
and blocking with 2% NCS in PBS for 30 min, primary antibody
against GAD65 (BD Pharmingen) and NF-200 (Abcam) or GFAP
(Deko) diluted (1:100) in blocking solution (2% NCS in PBS and 0.1%
Triton X-100 in PBS, pH 7.5) was applied for 2 h at room temper-
ature. The slides were then incubated with anti-rabbit Alexa Fluor
594 and anti-mouse Alexa Fluor 488-conjugated secondary anti-
bodies (Molecular Probes) in blocking solution for 1 h at room
temperature. To visualize the nuclei the Hoechst 33,258 dye (Invi-
trogen) was added to the wash buffer for 5 min after the secondary
antibody incubation. Coverslips were mounted on slides with
Mowiol (5% polyvinyl alcohol, [FLUKA], 12% glycerin, 50 mM Tris-
HCl, pH 8.5). Images of immunoﬂuorescence were acquired using
Zeiss LSM5 Exciter confocal microscope and ZEN 2009 software.
2.5. Application of tetrahydrocarbazoles
Selected tetrahydrocarbazoles that were able to stabilize an
increased Ca2þ efﬂux from the ER of HEK293-PS1 cells [21], here-
inafter referred to as numbers 1e7 (Table 1), were ordered from
ChemBridge. Compounds were added to each well at the ﬁnal
concentration of 10 mM in 0.02% dimethyl sulfoxide (DMSO). As a
control, MSN cultures were treated with 0.02% DMSO.
2.6. Single-cell Ca2þ measurements
Single-cell Ca2þ levels in MSNs were recorded using the ratio-
metric Ca2þ indicator Fura-2 acetoxymethyl ester (Fura-2 AM). Cells
grown on the 8-well chamber slides were loaded with 2 mM Fura-2
AM for 20 min at 37 C in a solution that contained 145 mM NaCl,Please cite this article in press as: M. Czeredys, et al., Tetrahydrocarbazole
YAC128 mice, a model of Huntington's disease, Biochemical and Bioph
j.bbrc.2016.08.1065 mM KCl, 0.75 mM Na2HPO4, 10 mM glucose, 10 mM HEPES (pH
7.4) and 1mMMgCl2 (HBSS) supplemented with 2mM CaCl2 (high-
Ca2þ medium) and then rinsed and left undisturbed for 15 min at
37 C to allow for de-esteriﬁcation. Measurements of intracellular
Ca2þ levels were performed every 1 s at 37 C using an Olympus
Cell^ R imaging software, an IX81 microscope, a 10x/0.4 UPlanSApo
objective (Olympus, Japan), and Hamamatsu EM-CCD C9100-02
camera (Hamamatsu Photonics, Japan). Intracellular Ca2þ levels in
individual neuronal cell bodies were expressed as the F340/F380
ratio after subtracting background ﬂuorescence. This ratio repre-
sents the emission intensities at 510 nm obtained after excitation at
340 and 380 nm. The low-Ca2þ medium (Ca2þ-free solution) con-
tained 0.1 mM EGTA in the standard buffer. To induce SOC channels
activity, two protocols were applied: either the use of an 8-well
system or a perfusion system (described in Fig. 2). Data process-
ing was performed using Olympus Cell^ R software, Microsoft Excel
and GraphPad Prism. In single-cell Ca2þ measurements, tetrahy-
drocarbazoles were added for 5 min before the start of the mea-
surements at a 10 mM concentration in HBSS buffer.
2.7. TUNEL staining experiments
The TUNEL staining experiments were performed as described
previously [23]. 14 day in vitro (DIV) MSNs were pre-incubated for
1 h with tetrahydrocarbazoles number 2 and 5 and added to the
culturemedium before the 8 h exposure to 100 mMglutamate in the
culture medium. During exposure to tetrahydrocarbazoles and
glutamate, the cells were kept in a cell culture incubator (humidi-
ﬁed 5% CO2, 37 C). Immediately after exposure to glutamate,
neurons were ﬁxed for 15 min in cold 4% paraformaldehyde and 4%
sucrose in PBS (pH 7.4), permeabilized for 5 min in 0.25% Triton X-
100, treated with RNase for 30 min and stained by using the
DeadEnd Fluorometric TUNEL System (Promega) according to the
manufacturer's instructions. Nuclei were counterstained with 5 mM
propidium iodide (PI). Coverslips were extensively washed with
PBS and mounted in Prolong Gold® antifade reagent (Molecular
Probes). FITC- and PI-ﬂuorescent images were taken with a Zeiss
LSM5 Exciter confocal microscope with a 40 objective. At least
three randomly chosen microscopic ﬁelds containing 100e150
MSNs were captured, and the number of TUNEL-positive neuronal
nuclei was calculated as a fraction of PI-positive neuronal nuclei in
each microscopic ﬁeld. Nuclei of glial cells, identiﬁed by large size
and weak PI staining, were not counted in the analysis.
2.8. Mitochondrial membrane potential (Djm) TMRM assay
The measurement method for the mitochondrial membrane
potential with tetramethylrhodamine methyl ester (TMRM) dye
was adapted from Refs. [21,24]. MSNs were seeded at the density of
70,000 cells per well on a Corning® BioCoat™ Poly-D-Lysine/Lam-
inin Cellware 8-Well Culture Slides and cultured up DIV 14. Cells
were then preincubated with tetrahydrocarbazoles (10 mM)
(Table 1), or 0.02% DMSO vehicle for 1 h, followed by the addition of
50 nM TMRM dye (Invitrogen). After 30 min, each well was washed
three times using phosphate-buffered saline. Fresh medium con-
taining each tested compound was added into the wells. Live-cell
image acquisition was performed using Olympus equipment and
software (described in Materials and methods: Single-cell Ca2þ
measurements) with  40 magniﬁcation. For TMRM excitation
(emission, > 560 nm), a 543 nm laser line was used, which corre-
sponds to Texas Red. After 5 min of measurements 1 mM carbonyl
cyanide 3-chlorophenylhydrazone (CCCP) from Sigma was applied
to determine changes in DJm, followed by the additional 5 min
live-cell imaging. Data analysis was adapted from Ref. [23]. The
mitochondrial puncta within each neuronal cell soma were chosens decrease elevated SOCE in medium spiny neurons from transgenic
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cence intensity of each ROI was deﬁned as F0. The change of TMRM
ﬂuorescence intensity in time was measured every 30 s, yielding
F(t). F(t) values from different experiments were normalized to F0
for all puncta (F/F0) and the data frommultiple cells were averaged
together. The time needed for F(t) to reach 0.8 F0was deﬁned as t0.8
and used for quantitative analysis. For the puncta that failed to
reach 0.8 F0 by the end of the experiment, the total recording time
(typically 800 s) was used as t0.8. The images were analyzed using
ImageJ software (NIH, Bethesda, MD, USA). All measurements were
performed at least three times.
2.9. ATP quantiﬁcation
The CellTiter-Glo® Luminescent Cell Viability Assay Kit (Prom-
ega) was used as a method to determine the ATP levels in HEK293
cultures treated with selected tetrahydrocarbazoles. It was based
on a quantiﬁcation of luminescence signal that was proportional to
the amount of ATP in the cell. Measurements were performed ac-
cording to manufacturer's instructions. HEK293 cells were seeded
at the density of 30,000 cells per well on a 96well Corning® Costar®
cell culture plates in Dulbecco's Modiﬁed Eagles Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and penicillinPlease cite this article in press as: M. Czeredys, et al., Tetrahydrocarbazol
YAC128 mice, a model of Huntington's disease, Biochemical and Biop
j.bbrc.2016.08.106(100 U/mL)/streptomycin (100 lg/mL). After 24 h the cells were
preincubated with tetrahydrocarbazoles (10 mM) or 0.02% DMSO
vehicle for 10 min or 1 h, followed by the addition of fresh medium
and CellTiter-Glo® Luminescent Cell Viability Assay. Luminescence
was measured in a Microplate Luminometer Centro XS3 LB 960
(Berthold Technologies). All measurements were performed three
times.
2.10. Statistical analysis
The statistical analyses were performed using Prism version
5.02 software (Graph-Pad, San Diego, CA, USA). The data are
expressed as the mean ± SEM from nMSNs (or glial cells) in at least
three separate primary cultures. Student's unpaired t-test and
Mann-Whitney or one-way ANOVA tests were used to analyze sets
of single cell Ca2þ measurement data or TUNEL, TMRM and ATP
assays, respectively. Tukey's post hoc test was used to determine
statistically signiﬁcant differences among groups in TUNEL and
TMRM experiments. Statistical comparison of the results obtained
in real-time PCR experiments with YAC128 and wild-type MSN
cultures was performed by student's unpaired t-test. The level of
signiﬁcance compared to that of controls is indicated by asterisks: *,
p < 0.05; **, p < 0.01; ***, p < 0.001; ns, not signiﬁcant, p > 0.05.es decrease elevated SOCE in medium spiny neurons from transgenic
hysical Research Communications (2016), http://dx.doi.org/10.1016/
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3.1. Disturbed Ca2þ homeostasis in YAC128 medium spiny neurons
MSN cultures were prepared from striata of day 18 embryos of
wild-type or hemizygous YAC128 mice. The presence of MSNs in
the cultures was conﬁrmed using antibodies against glutamate
decarboxylase (GAD), an enzyme that is present in nerve terminals
of MSNs [25]. Our cultures contained MSNs, together with other
neurons expressing a common neuronal marker, microtubule-
associated protein 2 (MAP2) (Fig. 1C) and glial cells expressing
glial ﬁbrillary acidic protein (GFAP) (Fig. 1D). On DIV 14, the level of
mRNA encoding HTT in YAC128 MSN cultures was increased 4000-
fold compared to wild-type MSN cultures, as found by real-time
PCR (Fig. 1A). HTT protein overexpression was conﬁrmed by west-
ern blot (Fig. 1B).
To verify the extent of dysfunction in Ca2þ homeostasis in these
MSN cultures, we compared Ca2þ signals in cells from YAC128 and
wild-type mice. We identiﬁed neurons from glial cells at the end of
each experiment by applying 56mMKCl. Neurons are characterized
by a fast response to high concentration of Kþ ions, which results in
the opening of voltage-gated calcium channels (VGCC) and a rapid
inﬂux of Ca2þ ions into the cytosol [26].
We ﬁrst measured Ca2þ ions entering the cytosol according to
the protocol shown in Fig. 2A. InsP3R-mediated Ca2þ efﬂux from ER
was induced with 20 mM dihydroxyphenylglycine (DHPG), anFig. 1. Characteristics of DIV14 MSN cultures from YAC128 mice. (1A) Gene expression a
YAC128 mice using real-time PCR. Gene expression results for huntingtin were normalized
shown as mean ± SEM and represent data based on three independent mRNA preparations o
YAC128 and wild-type MSN cultures. (1C) Immunostaining of GAD65 (MSNs marker, red) an
of GFAP (green) in glial cells present in MSN cultures. Hoechst staining (blue) showed nucl
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pathway [7,27]. Alternatively, Ca2þ release from the ER was ach-
ieved by addition of 0.5 mM thapsigargin (TG) to allow subsequent
SOCE. Either of these treatments was followed by the addition of
2 mM Ca2þ to the extracellular medium, which resulted in Ca2þ
inﬂux via SOCE (Fig. 2B or 2C).We detected a 40% increase in DHPG-
induced SOCE in YAC128 MSNs compared with control cells
(Fig. 2B) and an almost 20% increase in TG-induced SOCE (Fig. 2C),
which is in agreement with the data reported byWu and colleagues
[8,9].
Next, the protocol described in Fig. 2E for MSNs (Fig. 2F, G) and
in Fig. 2H for glial cells (Fig. 2I, J) was applied. This protocol enabled
us to check the level Ca2þ release from the ER, observed by the
addition of cyclopiazonic acid (CPA) in the presence of EGTA, which
was 17% bigger in the YAC128MSNs (Fig. 2F). 2mMCa2þ addition to
the medium resulted in a statistically signiﬁcant 16% increase of
Ca2þ inﬂux via CPA-induced SOCE (Fig. 2G). In contrast to MSNs,
there were no differences in CPA-induced SOCE and ER Ca2þ release
in glial cells from YAC128 compared to wild-type cells (Fig. 2I, J).
Basal Ca2þ levels, ER Ca2þ release, and SOCE were much greater in
YAC128 glial cells than YAC128MSNs. Glial cells were characterized
by an about 4.5-fold higher SOCE responses, a 5-fold higher Ca2þ
release from ER, and an about 20% higher basal Ca2þ levels
compared to MSNs (Fig. 2K, L, 2 M). Thus, mutated huntingtin af-
fects Ca2þ signals in neurons, but not in glial cells.
To conﬁrm that Ca2þ inﬂux was speciﬁcally mediated via SOCnalysis of mRNA encoding huntingtin (HTT) in the MSNs from wild-type (control) and
to Gapdh. Data from wild-type MSNs were normalized to a value of 1. The results are
f three different MSN cultures (***, p < 0.001). (1B) Immunoblots of HTT and GAPDH in
d MAP2 (neuronal marker, green). (1D) Immunostaining of GAD65 in neurons (red) and
ei of all cells.
s decrease elevated SOCE in medium spiny neurons from transgenic
ysical Research Communications (2016), http://dx.doi.org/10.1016/
Fig. 2. Parameters of Ca2þ homeostasis in YAC128 MSN. Cultures of medium spiny neurons (MSNs) at DIV 14 from YAC128 and wild-type mice (control) were loaded with Fura-
2AM (Ca2þ indicator) and incubated in Ca2þ-free media (0.1 mM EGTA). To induce SOCE using the 8-well system the protocol shown on (2A) was applied. In this protocol Ca2þ
release from the ER was induced by 20 mMDHPG indicated (a) or 0.5 mM of thapsigargin (TG) indicated (b). DHPG-induced SOCE (2B) or TG-induced SOCE (2C)was measured in the
8-well system in YAC128 and wild-type mouse MSNs. Inhibition of DHPG-induced SOCE in MSNs and glial cells from YAC128 mice by ML-9 (2D). To induce SOCE in the perfusion
system, the protocol shown on (2E) was applied for MSNs or on (2H) for glial cells: basal Ca2þ levels measured in 2 mM Ca2þ is indicated (c), Ca2þ release from the ER induced by
10 mM cyclopiazonic acid (CPA) is indicated (d), Ca2þ inﬂux via CPA-induced SOCE activated by addition of 2 mM Ca2þ to the medium is indicated (e). Blue letters (c, d, e) indicate
MSNs, green letters denote glial cells, black letters indicate comparison of YAC128 MSNs and glial cells. Using perfusion system, Ca2þ homeostasis in YAC128 and wild-type mouse
MSNs or glial cells was determined (2E or 2H). Ca2þ release from the ER for MSNs (2F) or for glial cells (2I), Ca2þ inﬂux via CPA-induced SOCE for MSNs (2G) or for glial cells (2J)was
analyzed. Differences in basal cytosolic Ca2þ levels between MSNs and glial cells from YAC128 mice are shown in (2K). Differences in depletion of intracellular Ca2þ stores between
MSNs and glial cells from YAC128 mice induced by CPA are shown in (2L), and variations in CPA-induced SOCE measured after addition of 2 mM Ca2þ to the media between MSNs
and glial cells from YAC128 mice are shown in (2M). The results are shown as mean ± SEM, number of cells is shown on the top of the bar, results of at least 3 independent MSN
cultures preparations are shown. (***, p < 0.001; ns- not signiﬁcant).
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Fig. 3. Effect of compounds number 2 and 5 on Ca2þ signals in MSNs. Medium spiny neurons cultures at DIV 14 from YAC128 and wild-type mice (control) were loaded with
Fura-2AM (Ca2þ indicator) and incubated in Ca2þ free media. MSN cultures were incubated for 5 min with compounds number 2, 5 or DMSO (control) in Ca2þ-free media or cells
were untreated. To measure DHPG-induced SOCE using the 8-well system (3A) or CPA-induced SOCE using perfusion system (3B) the protocols were applied as indicated. The effect
of compounds 2 and 5 on DHPG- and CPA-induced Ca2þ release from the ER (3C, 3D) and SOCE followed by a re-addition of 2 mM Ca2þ to the medium (3E, 3F). The effect of 0.02%
DMSO treatment for 5 min and 24 h on CPA-induced SOCE in YAC128 MSNs in the perfusion system (3G). The effect of compounds 2 and 5 on CPA-induced SOCE in control MSNs
using the perfusion system (3H). In the 8-well system protocol (3A), Ca2þ release from the ER induced by 20 mM DHPG is indicated as (a) and SOC channels activity induced by the
addition of 2 mM Ca2þ is indicated as (b). In the perfusion system protocol (3B), Ca2þ release from the ER induced by 10 mM CPA is indicated as (c), Ca2þ inﬂux via CPA-induced SOCE
induced by addition of 2 mM Ca2þ to the medium is indicated as (d). The results are shown as mean ± SEM, number of cells is shown on the top of the bar. (*, p < 0.05; **, p < 0.01;
***, p < 0.001; ns, not signiﬁcant, p > 0.05). Results were obtained from at least 3 independent MSN cultures preparations.
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reduced DHPG-induced SOCE in MSNs by about 35%, whereas in
glial cells, which feature more prominent SOCE (4.5 fold higher
than in YAC128 MSNs), ML-9 decreased SOC channels activity by
about 80% (Fig. 2D).
3.2. Effect of tetrahydrocarbazoles on SOCE and Ca2þ release from
ER in YAC128 MSNs
We showed previously that tetrahydrocarbazoles stabilize the
ER Ca2þ release induced by carbachol in HEK293-PS1-M146L cells, a
cellular model of familial Alzheimer's disease [21]. In the present
work we investigated the potential of seven selected tetrahy-
drocarbazoles (Table 1) to attenuate the elevated ER Ca2þ release
and increased SOCE in YAC128 MSNs. SOCE was measured by two
methods (Fig. 3A, B). Among seven chemicals used, ﬁve were
ineffective. Two tetrahydrocarbazoles, numbered 2 and 5,
normalized SOC channel activity by 10% and 15% respectively in
YAC128 MSN cultures after activation of InsP3R1 by DHPG (Fig. 3E)
and by 14% and 10% respectively after inhibition of SERCA by CPA
(Fig. 3F). After the treatment with compound 2 or 5 the level of SOC
channel activity in YAC128 MSN cultures were indistinguishable
from that observed in wild-type MSN cultures (Fig. 3E, F). Tetra-
hydrocarbazoles were able to decrease ER Ca2þ release induced by
DHPG or CPA, but the effect was not statistically signiﬁcant (Fig. 3C
and D). Moreover, we determined that a 5 min application of 0.02%
DMSO did not affect CPA-induced SOCE in YAC128 MSNs (Fig. 3G).
Interestingly, we did not observe any effect of compound 2 on CPA-
induced SOCE in cells from wild-type animals, in contrast to com-
pound 5, which decreased SOCE signiﬁcantly by about 25% in
control MSNs (Fig. 3H). Mean ± SEM values for SOCE and ER Ca2þ
release in wild-type and YAC128 MSNs treated with compounds 2
and 5 are shown in Table 2. We concluded that compound 2 (6-
bromo-N-(2-phenylethyl)-2,3,4,9-tetrahydro-1H-carbazol-1-
amine hydrochloride) has a speciﬁc effect on the stabilization of the
DHPG- and CPA-induced SOCE in MSNs from YAC128 mice.
3.3. Tetrahydrocarbazoles 2 and 5 do not affect cell death induced
by glutamate in MSN cultures from YAC128 and wild-type mice
The MSN cultures from wild-type and YAC128 mice were un-
treated or treated by glutamate (100 mM) for 8 h as described
previously [23] and analyzed for cell death by TUNEL staining with
propidium iodide counterstaining. In line with the ﬁndings of
Zhang and colleagues [23] there was no statistically signiﬁcant
difference between wild-type and YAC128 MSNs - approximately
about 9% versus 14% of TUNEL-positive cells in the cultures were
apoptotic (Fig. 4C). Application of 100 mM glutamate increased
apoptotic cell death to 30e40% inwild-type and 60e70% in YAC128
MSNs as described previously [23]. As a positive control we added
DNaseI (10U/ml) for 10 min to YAC128 MSN cultures, which
resulted in an induction of cell death at the level of about 52%
(Fig. 4C).
In the next experiments we tested whether theTable 2
Mean ± SEM values for SOCE and ER Ca2þ release in wild-type and YAC128 MSNs treate
YAC128
DMSO Compound 2
SOCE 8-well system 1 ± 0.02 0.89 ± 0.04
Perfusion system 1 ± 0.03 0.87 ± 0.05
CPA-induced Ca2þ release 1 ± 0.08 0.77 ± 0.13
DHPG-induced Ca2þ release 1 ± 0.22 0.86 ± 0.24
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glutamate-induced cell death in MSN cultures. The 14 DIV MSNs
cultures fromwild-type and YAC128 mice were pre-incubated with
tetrahydrocarbazoles 2 and 5 or 0.02% DMSO for 1 h and then the
cells were treated with 100 mM glutamate for 8 h. We did not
observe any changes in the sensitivity to glutamate-induced cell
death in the cells pre-incubated with compound 2 or 5 (Fig. 4D).
This indicates that although both compounds were able to correct
elements of Ca2þ homeostasis (Fig. 3E, F), they had no beneﬁcial
effects on the pathways disturbed by glutamate.
3.4. Tetrahydrocarbazoles increase the mitochondrial membrane
potential in YAC128 MSNs
Cardenas and colleagues indicated that the ER physically in-
terfaces with mitochondria and that Ca2þ shuttling between these
two organelles through InsP3Rs plays a critical role in the regula-
tion of mitochondrial function [29]. Constitutive Ca2þ release from
InsP3R to mitochondria is a crucial mechanism involved in mito-
chondrial function. Mutant HTT that affects InsP3R1 [7] may play a
role in the physical interaction between ER and mitochondria,
leading to altered shuttling of Ca2þ between the two organelles and
in the modulation of the mitochondrial Ca2þ uptake. We found that
depolarization of the mitochondrial membrane potential by the
addition of 1 mM CCCP resulted in a much more rapid loss of TMRM
ﬂuorescence in YAC128MSNs compared towild-type cells (Fig. 5A).
We next checked if compounds 2 and 5 inﬂuence themitochondrial
membrane potential measured with TMRM as previously described
[21]. Indeed, a 1 h pretreatment of MSNs from YAC128 with
selected tetrahydrocarbazoles led to a remarkable increase in the
mitochondrial membrane potential, measured by the TMRM ﬂuo-
rescence signal, but this effect was not observed in wild-type MSNs
(Fig. 5A). After the treatment with compound 2 or 5 at a 10 mM
concentration the level of the mitochondrial membrane potential
in YAC128 MSN cultures was indistinguishable from that observed
in wild-type MSN cultures. To measure the differences between
YAC128 and wild-type MSNs we determined a time (t0.8) necessary
for F(t) to become equal to 0.8 of F0 for each cell. We found that
average t0.8 values were signiﬁcantly reduced in experiments with
YAC128 MSNs compared to wild-type cells (Fig. 5B). In contrast, we
observed a signiﬁcant difference in average t0.8 values for YAC128
MSNs pretreated with compounds number 2 and 5 compared to
YAC128 MSNs treated with DMSO (Fig. 5B). Thus, we observed that
CCCP treatment resulted in a more rapid loss of TMRM ﬂuorescence
in YAC128 MSNs and this observation was reversed by tetrahy-
drocarbazoles. We next checked the level of ATP production in
HEK293 cells after application of tetrahydrocarbazoles for 10 min
and 1 h. We did not observe any signiﬁcant changes in ATP con-
centration after the treatment with the selected compounds vs
DMSO as a control (Fig. 5C).
4. Discussion
Several studies have investigated the dysfunction of Ca2þd by tetrahydrocarbazoles.
Wild-type
Compound 5 DMSO Compound 2 Compound 5
0.86 ± 0.04 e e e
0.93 ± 0.02 1 ± 0.05 1.02 ± 0.04 0.75 ± 0.03
0.93 ± 0.13 e e e
e e e e
es decrease elevated SOCE in medium spiny neurons from transgenic
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Fig. 4. Effect of tetrahydrocarbazoles number 2 and 5 on cell death detected by the TUNEL test in YAC128 and wild-type MSNs. DIV 14 MSNs were ﬁxed, permeabilized and
analyzed by TUNEL staining (DNA strand breaks were detected as green dots) and propidium iodide counterstaining (red) showed the nuclei of all cells (MSNs have small nuclei,
glial cells have big nuclei). Cell death in wild-type MSN cultures (4A). Cell death in YAC128 MSN cultures (4B). Cell death was induced in YAC128 and wild-type DIV14 MSNs by an
8 h treatment using 100 mM glutamate (E) (4C). As a positive control, DNaze I was applied. YAC128 and wild-type MSNs were treated for 1 h with compounds number 2, 5 or DMSO
(control) and then for 8 h with glutamate (4D). The fraction of TUNEL-positive MSN nuclei was calculated and the data are shown as mean ± SEM for each condition (n ¼ 5e9
microscopic ﬁelds, at least two independent MSN preparations, 100e150 MSN per ﬁeld). At 100 mM glutamate, the fraction of TUNEL-positive MSN is signiﬁcantly (***, p < 0.001)
higher for YAC128 MSNs than for wild-type and for un-treated YAC128 MSNs as well as in control conditions for YAC128 MSNs treated by DNazeI than for un-treated YAC128 MSNs
(4C). The fraction of TUNEL-positive MSNs is signiﬁcantly (*, p < 0.05) higher for wild-type at 100 mM glutamate than for not-treated wild-type MSNs (4C). For wild-type and YAC128
MSNs pretreated for 1 h with 10 mM tetrahydrocarbazoles number 2 and 5 and then treated by 100 mM glutamate for 8 h (4D) no signiﬁcant changes were observed (ns, not
signiﬁcant, p > 0.05).
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[8e10,30]. We expanded these studies to MSNs isolated from
YAC128 transgenic mice because they express the full-length hu-
man HTT protein with 128 CAG repeats and display an age-
dependent loss of striatal neurons similar to human HD [31].
We observed a 40% increase in DHPG-induced SOCE and an
almost 20% in TG- and CPA-induced SOCE in YAC128 MSNs
compared with wild-type cells. All changes in Ca2þ signals werePlease cite this article in press as: M. Czeredys, et al., Tetrahydrocarbazole
YAC128 mice, a model of Huntington's disease, Biochemical and Bioph
j.bbrc.2016.08.106speciﬁc for MSNs, since no changes were found in glial cells. These
differences can probably be explained by the dual activity of DHPG,
which can activate InsP3R1 and induce SOCE [32], as well as acti-
vate TRPC channels [33], whereas TG and CPA are both SERCA
blockers. The increases observed in this report are in linewith those
shown by Wu and colleagues [8]. ML-9, a SOCE inhibitor, did not
completely decrease DHPG-induced SOCE, which indicates that
some Ca2þ entry occurred through ML-9-insensitive channels likes decrease elevated SOCE in medium spiny neurons from transgenic
ysical Research Communications (2016), http://dx.doi.org/10.1016/
Fig. 5. Effect of tetrahydrocarbazoles 2 and 5 on the mitochondrial membrane
potential in YAC128 and wild-type MSNs. The average normalized F/F0 traces for
YAC128 and wild-type MSNs upon a 1 h treatment with tetrahydrocarbazoles number
2 and 5 (10 mM) or 0.02% DMSO (negative control) in the presence of CCCP (1 mM) (5A).
The average t0.8 time is shown for each cell group as mean ± SEM. The YAC128 MSNs
mitochondrial membrane depolarized much more readily than in wild-type cells (**,
p < 0.01). The difference is abolished in the presence of tetrahydrocarbazoles number 2
(*, p < 0.05) and 5 (**, p < 0.01. (5B). Quantiﬁcation of luminescence signal which was
proportional to the amount of ATP produced in HEK293 cells upon treatment with
tetrahydrocarbazoles for 10 min (p > 0.05) and 1 h (p > 0.05) (5C) (ns, not signiﬁcant;
**, p < 0.01 and ***, p < 0.001; n ¼ 20e25 cells obtained in 3 independent MSNs
preparations; n ¼ 3 independent HEK293 cultures). DMSO, dimethyl sulfoxide; TMRM,
tetramethylrhodamine methyl ester; CCCP, carbonyl cyanide 3-
chlorophenylhydrazone.
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lation of disturbed SOC channels activity [8,10].
The statistically signiﬁcant increase of Ca2þ release from the ER
is likely caused by InsP3R1 receptor over-activation [7], which may
in turn affect SOCE in HD. Since the function of InsP3R1 is disturbed
in HD, we investigated the effect of compounds called tetrahy-
drocarbazoles, whichwere shown to stabilize the ER Ca2þ release in
an AD cellular model at a concentration of 10 mM [21]. Two of them
(compounds 2 and 5) were able to rescue the increased DHPG- and
TG/CPA-induced SOCE in YAC128 MSNs. The effect on the increased
Ca2þ release from the ER was, however, not statistically signiﬁcant,
both when CPA was used to inhibit SERCA or when DHPG was
applied to activate InsP3R. Only compound 2 (6-bromo-N-(2-
phenylethyl)-2,3,4,9-tetrahydro-1H-carbazol-1-amine hydrochlo-
ride) had a speciﬁc effect on rescuing SOCE in YAC128 MSNs. The
other one (compound 5) decreased SOCE also in control MSNs. We
think that compound 2 acts through a post-translational modiﬁ-
cation of proteins involved in SOCE or stabilization of the cyto-
skeleton, since it was added only 5 min before the Ca2þ
measurements. It was reported that stabilization of actin may
decrease SOCE [34]. Another possibility is that compound 2 may
bind to SOCE channels or ER Ca2þ release channels and inhibit
them. However, its effect on the increased Ca2þ release from ERwas
not statistically signiﬁcant, in contrast to its effect on SOCE.
Mutant HTT facilitates the activity of the NR2B subtype of NMDA
receptors [23,35] and InsP3R1 [7,36]. Moreover, elevated Ca2þ
levels have been directly linked to cell death in striatal MSNs
cultured from HD mouse models [37e39]. Untreated YAC128 and
wild-type MSNs were found to have a similar rate of cell death.
However, 100 mM glutamate signiﬁcantly increased cell death in
YAC128 MSNs compared to wild-type MSNs. We did not observe
any beneﬁcial effects of either tetrahydrocarbazole on glutamate-
induced cell death. This indicates that the pathways responsible
for glutamate-induced cell death, involving the NR2B subtype of
NMDA receptors [23], are not targeted by these chemicals.
An increased Ca2þ inﬂux via NMDA receptors and Ca2þ release
via the InsP3R1 were shown in HDmodels. Both processes cause an
elevation of intracellular Ca2þ levels in HD MSNs, abnormal Ca2þ
accumulation in mitochondria and degeneration of MSNs [4]. An
effect of mutant HTT on mitochondrial membrane ion permeability
was observed [40]. We detected signiﬁcant changes of mitochon-
drial membrane potential between wild-type and YAC128 MSNs.
This is in line with ﬁndings of Zhang and colleagues, who showed
that application of glutamate causes a rapid loss of mitochondrial
membrane potential in YAC128 MSNs, in contrast to wild-type cells
[23]. We explored whether both active tetrahydrocarbazoles
improve mitochondrial function, and found a statistically signiﬁ-
cant increase of membrane potential after the application of tet-
rahydrocarbazole number 2 and 5 in YAC128 MSN cultures, but not
in wild-type neurons. Using an AD model, Honarnejad and col-
leagues [21] found that tetrahydrocarbazoles increase mitochon-
drial membrane potential even more efﬁciently than Dimebon, a
known enhancer of mitochondrial activity [41]. We did not observe
any signiﬁcant changes in ATP production in HEK293 cells treated
with selected tetrahydrocarbazoles compared to control condi-
tions. This could indicate that the effects of compounds number 2
and 5 on mitochondria are beneﬁcial.
We have shown that selected tetrahydrocarbazoles stabilize
deranged Ca2þ signaling in YAC128 MSNs. Therefore, a possible
explanation of their beneﬁcial effect on mitochondria is that they
prevent the abnormal Ca2þ accumulation in these organelles.
Recently, Wang and colleagues stimulated Ca2þ mobilization in
MSNs by activating group I metabotropic glutamate receptors and
triggering InsP3R production and found a signiﬁcantly higher Ca2þ
load in mitochondria in neurons from YAC128 mice compared withes decrease elevated SOCE in medium spiny neurons from transgenic
hysical Research Communications (2016), http://dx.doi.org/10.1016/
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observed a stabilization of mitochondrial membrane potential in
YAC128 MSNs treated by compounds number 2 and 5. Further
studies are required to determine the potential target(s) of tetra-
hydrocarbazoles and the effect of their different stereoisomers and
concentration (racemic mixtures at a 10 mM concentration were
used).
In conclusion, our data provide additional evidence for the
importance of deranged Ca2þ signaling in HD pathology, in
particular elevated SOCE. The observed abnormalities in Ca2þ
signaling in MSN cultures from YAC128 mice correlate with in vivo
pathology described for these mice [31]. Furthermore, the present
work identiﬁed a compound having a novel function of restoring
the level of SOCE in YAC128 MSNs. The stabilization of Ca2þ
signaling by the identiﬁed tetrahydrocarbazole was accompanied
by a lack of effect on glutamate-induced cell death in YAC128 MSN
cultures, but by a beneﬁcial inﬂuence on mitochondrial function.
This compound (6-bromo-N-(2-phenylethyl)-2,3,4,9-tetrahydro-
1H-carbazol-1-amine hydrochloride) should be considered as a
potential lead structure for HD treatment.
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